JPWO2021019092A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021019092A5
JPWO2021019092A5 JP2022506666A JP2022506666A JPWO2021019092A5 JP WO2021019092 A5 JPWO2021019092 A5 JP WO2021019092A5 JP 2022506666 A JP2022506666 A JP 2022506666A JP 2022506666 A JP2022506666 A JP 2022506666A JP WO2021019092 A5 JPWO2021019092 A5 JP WO2021019092A5
Authority
JP
Japan
Prior art keywords
weight
premix
topical gel
adapalene
gel formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506666A
Other languages
Japanese (ja)
Other versions
JP2022542616A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/071715 external-priority patent/WO2021019092A1/en
Publication of JP2022542616A publication Critical patent/JP2022542616A/en
Publication of JPWO2021019092A5 publication Critical patent/JPWO2021019092A5/ja
Pending legal-status Critical Current

Links

Claims (9)

1~1.5重量%のクリンダマイシンリン酸エステル、2.5~3.5重量%の過酸化ベンゾイル、および、0.1~0.2重量%のアダパレンを、ゲル化剤、多価アルコール、および水と組み合わせて、含む、局所ゲル製剤。 1-1.5% by weight of clindamycin phosphate, 2.5-3.5% by weight of benzoyl peroxide, and 0.1-0.2% by weight of adapalene as a gelling agent, polyvalent Topical gel formulations, including in combination with alcohol and water. 約1.2重量%のクリンダマイシンリン酸エステル、約3.1重量%の過酸化ベンゾイル、および約0.15重量%のアダパレン、を含む、請求項1に記載の局所ゲル製剤。 2. The topical gel formulation of claim 1, comprising about 1.2% by weight clindamycin phosphate, about 3.1% by weight benzoyl peroxide, and about 0.15% by weight adapalene. 製剤が、
a.約1.2重量%のクリンダマイシンリン酸エステル、
b.約3.1重量%の過酸化ベンゾイル、
c.約0.15重量%のアダパレン、
d.約5重量%のプロピレングリコール、
e.約1.75重量%のカルボマーホモポリマータイプC、
f.pH5~6をもたらす量の水酸化カリウム、および、
g.水、
を含む、請求項2に記載の局所ゲル製剤。
the formulation is
a. about 1.2% by weight of clindamycin phosphate;
b. about 3.1% by weight of benzoyl peroxide;
c. about 0.15% by weight of adapalene;
d. about 5% by weight of propylene glycol;
e. about 1.75% by weight of carbomer homopolymer type C;
f. Potassium hydroxide in an amount to provide a pH of 5-6, and
g. water,
3. The topical gel formulation of claim 2, comprising:
治療を必要とする患者において、尋常性座瘡またはアクネを治療するための請求項1~3のいずれか1項に記載の局所ゲル製剤。 A topical gel formulation according to any one of claims 1 to 3 for treating acne vulgaris or acne in a patient in need thereof. 少なくとも1日1回、患者の患部に投与される、請求項4に記載の局所ゲル製剤。 5. The topical gel formulation of claim 4, which is administered to the patient's affected area at least once a day. 少なくとも12週間を含めた少なくとも4週間、1日1回、患者の患部に投与される、請求項4または5に記載の局所ゲル製剤。 6. The topical gel formulation of claim 4 or 5, administered to the patient's affected area once daily for at least 4 weeks, including at least 12 weeks. 治療が、(i)1~1.5重量%のクリンダマイシンリン酸エステル、および2.5~3.5重量%の過酸化ベンゾイル、(ii)2.5~3.5重量%の過酸化ベンゾイル、および0.1~0.2重量%のアダパレン、および、(iii)1~1.5重量%のクリンダマイシンリン酸エステル、および0.1~0.2重量%のアダパレン、から選択される有効成分を含む製剤による治療よりも、アクネの治療においてより効果的である、請求項4、5、または6に記載の局所ゲル製剤。 The treatment comprises (i) 1-1.5 wt% clindamycin phosphate and 2.5-3.5 wt% benzoyl peroxide, (ii) 2.5-3.5 wt% excess from benzoyl oxide and 0.1-0.2% by weight adapalene and (iii) 1-1.5% by weight clindamycin phosphate and 0.1-0.2% by weight adapalene 7. The topical gel formulation of claim 4, 5, or 6, which is more effective in treating acne than treatment with a formulation containing the selected active ingredient. ポンプを備えた容器、および請求項1~7のいずれか1項に記載の局所ゲル製剤を含む、医薬品であって、ポンプが押されるごとに特定の量の製剤を放出するようにポンプが調整されている、医薬品。 A pharmaceutical product comprising a container provided with a pump and a topical gel formulation according to any one of claims 1 to 7, the pump being adjusted to release a specific amount of the formulation each time the pump is pressed. Pharmaceuticals. 請求項1~7のいずれか1項に記載の局所ゲル製剤を製造する方法であって、
i.下記のプレミックス:
a)水に分散したゲル化剤を含む、プレミックスA、
b)多価アルコールと水に分散した過酸化ベンゾイルを含む、プレミックスB、
c)クリンダマイシンリン酸エステルの水溶液を含む、プレミックスC、
d)多価アルコールと水に分散した微粉化アダパレンを含む、プレミックスD、を提供すること、
ii.プレミックスAとプレミックスDを混合すること、
iii.プレミックスBを、工程iiの混合物に混合すること、
iv.プレミックスCを、工程iiiの混合物に混合すること、
v.工程ivの混合物のpHをpH5~6に調整して、ゲルを形成すること、
を含む、方法。
A method for producing a topical gel formulation according to any one of claims 1 to 7,
i. Premixes for:
a) a premix A comprising a gelling agent dispersed in water,
b) Premix B, comprising polyhydric alcohol and benzoyl peroxide dispersed in water,
c) Premix C, containing an aqueous solution of clindamycin phosphate,
d) providing a premix D comprising micronized adapalene dispersed in a polyhydric alcohol and water;
ii. mixing premix A and premix D;
iii. mixing premix B into the mixture of step ii;
iv. mixing premix C into the mixture of step iii;
v. adjusting the pH of the mixture of step iv to pH 5-6 to form a gel;
A method, including
JP2022506666A 2019-08-01 2020-07-31 topical composition Pending JP2022542616A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881836P 2019-08-01 2019-08-01
US62/881,836 2019-08-01
PCT/EP2020/071715 WO2021019092A1 (en) 2019-08-01 2020-07-31 Topical compositions

Publications (2)

Publication Number Publication Date
JP2022542616A JP2022542616A (en) 2022-10-05
JPWO2021019092A5 true JPWO2021019092A5 (en) 2023-08-07

Family

ID=71899773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506666A Pending JP2022542616A (en) 2019-08-01 2020-07-31 topical composition

Country Status (9)

Country Link
US (2) US11389467B2 (en)
EP (1) EP4007566A1 (en)
JP (1) JP2022542616A (en)
CN (1) CN114126582A (en)
AU (1) AU2020322173A1 (en)
CA (1) CA3149296A1 (en)
CO (1) CO2022002253A2 (en)
MX (1) MX2022001138A (en)
WO (1) WO2021019092A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022001138A (en) * 2019-08-01 2022-02-16 Bausch Health Ireland Ltd Topical compositions.
CN113350273A (en) * 2021-05-31 2021-09-07 辰欣药业股份有限公司 Clindamycin phosphate injection and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR054805A1 (en) * 2005-06-29 2007-07-18 Stiefel Laboratories TOPICAL COMPOSITIONS FOR SKIN TREATMENT
MXPA06008988A (en) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide).
CN101485675B (en) * 2008-01-18 2012-05-02 兆科药业(合肥)有限公司 Adapalene and hydrochloric clindamycin compound gel preparation and preparation method thereof
US8288434B2 (en) * 2008-06-05 2012-10-16 Dow Pharmaceutical Sciences, Inc. Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
WO2016069952A1 (en) * 2014-10-31 2016-05-06 Sreedhar Rao Rayudu Anti-acne composition and methods of use
US20180235924A1 (en) * 2015-08-20 2018-08-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
MX2022001138A (en) * 2019-08-01 2022-02-16 Bausch Health Ireland Ltd Topical compositions.

Similar Documents

Publication Publication Date Title
DK2450035T3 (en) Combination of adapalene and benzoyl peroxide for the treatment of acne lesions
US6838095B2 (en) Ionic silver complex
KR101014586B1 (en) Gel comprising at least a retinoid and benzoyl peroxide
KR101500767B1 (en) Cream-gel comprising at least one retinoid and benzoyl peroxide
US5616347A (en) Chlorine dioxide skin medicating compositions for preventing irritation
JP5317968B2 (en) A composition comprising a retinoid and benzoyl peroxide
KR20080059143A (en) Topical skin treating compositions
EP3182957B1 (en) Cineole-containing composition for nasal application
US8846646B2 (en) Topical treatment of skin infection
JP2012514030A (en) Topical herbal preparations for the treatment of acne and skin disorders
US11690815B2 (en) Hyperkeratotic skin condition treatments and compositions
EP2817069A1 (en) Composition comprising a retinoid and benzoyl peroxide
CN113226251B (en) Suspension formulations of high load dispersions
US20100004338A1 (en) Topical gel composition comprising azelaic acid
CA2979730A1 (en) Treatment of acne vulgaris with sequential topical formulations comprising antimicrobial organic acid anions in alkaline phase
JPWO2021019092A5 (en)
CN102670648A (en) Liquid iodine disinfectant, preparation method and used container thereof
EP3941454A1 (en) Topical compositions and methods for treating acne vulgaris
JP2009155219A (en) Warm patch
RU2022104310A (en) COMPOSITIONS FOR TOPICAL APPLICATION
JP5299449B2 (en) External preparation composition
EP3171857B1 (en) Combination of adapalene and benzoyl peroxide for the treatment of severe acne
US20210290665A1 (en) Topical composition for treatment of pain and symptoms associated with rhinosinusitis, method of making, and method of use
CN110013479A (en) A kind of Chinese medicine composition for preventing and treating whelk
MXPA01005900A (en) Ionic silver complex